The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...

It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...

From July 24 to 26, 2024, Porter Novelli Public Services fielded a nine-question online survey developed with the CDC to ...

FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or ...

Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...

With fluctuating weather conditions, a decrease in temperatures, and many residents returning from summer vacations, there ...

Houston emergency room physician, Dr. Christopher Langan, is urging parents to give their children flu shots between now and end of October to minimize the chances of severe illnesses and ...

Experienced Life Sciences Executive Brings Strategic Expertise to Support Traws’ Further Transformation and Growth Director ...

Roche RHHBY announced positive top-line results from a late-study on influenza drug, Xofluza. The CENTERSTONE study was a global phase III trial investigating the efficacy of single-dose Xofluza, ...

WHO calls for action for its 79th session of the UN General Assembly to address the ongoing issues of antimicrobial ...

Mysterious fever outbreak in remote Gujarat villages claims 19 lives, sparking panic and health concerns in the community.

The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...